Both I‐BET151 and JQ1 are BET inhibitors.[36, 59] In particular, JQ1 in combination with PD‐1 blockade, was reported to enhance anti‐tumor immunity in colorectal cancer.[60] We studied potential molecular mechanisms underlying immune relevant functions of these epigenetic inhibitors. Here, DNER is linked to colorectal cancer.